Skip to main content
Clinical Trials/JPRN-UMIN000032040
JPRN-UMIN000032040
Completed
未知

The exploratory study on change of the gutmicrobiota in Rabeprazole divided doses:Direction crossover controlled trial in front of an open label - The exploratory study on change of the gutmicrobiota in the Rabeprazole administration

Shiga University of Medical Science0 sites12 target enrollmentApril 1, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Reflux esophagitis.
Sponsor
Shiga University of Medical Science
Enrollment
12
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2018
End Date
March 31, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.No consent 2\.With the drug including a suppressant acid\-secreting for the past one month. 3\.With probiotics (medicine for intestinal disorders) or the antimicrobial agent for the past one month. 4\.With grapefruits for the past two weeks. 5\.With operating treatment for upper gastrointestinal disease including esophagus and stomach. 6\.During pregnancy or nursing.

Outcomes

Primary Outcomes

Not specified

Similar Trials